Back
Tekla Healthcare Opportunities Fund Vs. VanEck Pharmaceutical ETF Industry Stock Comparison
Sell
41
THQ
Tekla Healthcare Opportunities Fund
Last Price:
20.27
Seasonality Move:
-3.33%
Buy
55
PPH
VanEck Pharmaceutical ETF
Last Price:
91.24
Seasonality Move:
-1.72%
Sell
41
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $20.25. The Score for THQ is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
VanEck Pharmaceutical ETF (PPH)
is a Buy
Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?
- The current VanEck Pharmaceutical ETF [PPH] share price is $90.59. The Score for PPH is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $20.25
The current trend is moderately bullish and THQ is experiencing selling pressure, which indicates risk of future bearish movement.
PPH Stock Price Chart
What is VanEck Pharmaceutical ETF's stock price today?
-
The VanEck Pharmaceutical ETF share price today is $90.59
The current trend is moderately bearish and PPH is experiencing slight selling pressure.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 51.78 | Buy |
| Chaikin Money Flow: | -49411 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.95 - 20.39) | Buy |
| Bollinger Bands (100): | (19.45 - 20.27) | Buy |
PPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 43.3 | Sell |
| Chaikin Money Flow: | -9127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.56 - 92.62) | Sell |
| Bollinger Bands (100): | (87.44 - 91.36) | Buy |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.32 | Sell |
| 20-day SMA: | 20.26 | Sell |
| 50-day SMA: | 20.09 | Buy |
| 200-day SMA: | 18.63 | Buy |
| 8-day EMA: | 20.3 | Sell |
| 20-day EMA: | 20.25 | Buy |
| 50-day EMA: | 20.07 | Buy |
| 200-day EMA: | 19.28 | Buy |
PPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.92 | Sell |
| 20-day SMA: | 91.98 | Sell |
| 50-day SMA: | 90.16 | Buy |
| 200-day SMA: | 84.94 | Buy |
| 8-day EMA: | 91.51 | Sell |
| 20-day EMA: | 91.52 | Sell |
| 50-day EMA: | 90.49 | Buy |
| 200-day EMA: | 86.18 | Buy |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
VanEck Pharmaceutical ETF Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||